Form 4: Bio-Rad Laboratories Director Exercises Restricted Stock Units

Charles M. Watts, a director at Bio-Rad Laboratories, exercised restricted stock units (RSUs) on March 31, 2025, acquiring 46,686 shares of common stock.

Summary

• On March 31, 2025, Charles M. Watts, a director of BIODESIX INC, executed a transaction involving restricted stock units.
• Watts acquired 46,686 shares of common stock through the exercise of these RSUs.
• Following the transaction, Watts directly owns 421,705 shares of BIODESIX INC common stock.
• The restricted stock units vested fully on March 31, 2025, and do not have an expiration date.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction by a company director. It's a routine filing and doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This filing indicates a director exercising vested stock options, which is a common occurrence.

Stakeholder Impact

• The transaction could have a minor impact on shareholders due to the increase in the number of outstanding shares, but the effect is likely minimal given the size of the transaction relative to the overall market capitalization of the company.

Key Dates

Keywords

BIODESIX INC, Director, RSU, Stock, Form 4, Watts, Exercise